Stefan Weiler
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 8
- Epidemiology 11
- Co-authors
- Andrea M. Burden (16 shared papers)Romuald Bellmann (13 shared papers)Michael Joannidis (10 shared papers)Gerd A. Kullak‐Ublick (9 shared papers)Benjamin Misselwitz (2 shared papers)Alexander A. Tarnutzer (2 shared papers)Christopher J. Bockisch (1 shared paper)Konrad P. Weber (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Swiss Medical Weekly (5 papers)European Journal of Clinical Pharmacology (3 papers)Journal of Clinical Medicine (3 papers)Toxicon (3 papers)
- Partner nations
- SwitzerlandAustriaGermany
In The Last Decade
Stefan Weiler
64 papers receiving 805 citations
Stefan Weiler's Hit Papers
Peers
Comparison fields: 5 of 108
- Hepatology 83
- Infectious Diseases 148
- Neurology 65
- Epidemiology 187
- Pharmacology 96
Countries citing papers authored by Stefan Weiler
This map shows the geographic impact of Stefan Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Weiler more than expected).
Fields of papers citing papers by Stefan Weiler
This network shows the impact of papers produced by Stefan Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Weiler. The network helps show where Stefan Weiler may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Weiler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 101 | |
| 2 | 2016 | 70 | |
| 3 | Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality Hit paper breakdown → | 2024 | 55 |
| 4 | 2021 | 50 | |
| 5 | 2013 | 49 | |
| 6 | 2010 | 37 | |
| 7 | 2020 | 33 | |
| 8 | 2015 | 32 | |
| 9 | 2018 | 24 | |
| 10 | 2009 | 22 | |
| 11 | 2007 | 22 | |
| 12 | Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration. | 2010 | 22 |
| 13 | 2016 | 21 | |
| 14 | 2014 | 20 | |
| 15 | 2020 | 17 | |
| 16 | 2016 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2018 | 12 | |
| 19 | 2011 | 11 | |
| 20 | 2012 | 10 |
About Stefan Weiler
Stefan Weiler is a scholar working on Infectious Diseases, Epidemiology, Genetics, Pharmacology and Pharmacology, having authored 71 papers that have together received 823 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (8 papers), Venomous Animal Envenomation and Studies (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Rabies epidemiology and control (4 papers), Poisoning and overdose treatments (3 papers) and Quality and Supply Management (3 papers). The work is most often cited by research in Hepatology (83 citations), Infectious Diseases (148 citations), Neurology (65 citations), Epidemiology (187 citations) and Pharmacology (96 citations). Stefan Weiler has collaborated with scholars based in Switzerland, Austria and Germany. Frequent co-authors include Andrea M. Burden, Romuald Bellmann, Michael Joannidis, Gerd A. Kullak‐Ublick, Benjamin Misselwitz, Alexander A. Tarnutzer, Christopher J. Bockisch, Konrad P. Weber, Lucas M. Bachmann and Chiara Gastaldon. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Swiss Medical Weekly, European Journal of Clinical Pharmacology, Journal of Clinical Medicine and Toxicon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.